비교리스트

 카트 문의
시장보고서
상품코드
1575009

페니실린 제제 시장 : 유형별, 투여 경로별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Penicillin Drug Market, By Type, By Route of Administration, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 269 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

페니실린 제제 시장 규모는 2023년 91억 232만 달러로 2024년부터 2032년까지 CAGR 4.20%로 확대될 전망입니다.

페니실린 제제 시장 - 시장 역학

항생제 처방 증가로 페니실린 제제 시장 성장 촉진

항생제 처방의 증가는 세균 감염의 증가와 고령화 인구의 증가로 인해 페니실린 제제 시장을 크게 견인하고 있습니다. 세계보건기구(WHO)에 따르면 항생제 내성은 전 세계 보건 문제로 효과적인 치료에 대한 수요가 증가하고 있으며, 2021년 미국 질병예방통제센터는 미국에서만 연간 항생제 처방이 2억 건을 넘어섰다고 보고했으며, 페니실린 유도체는 여전히 연쇄상 구균 감염, 폐렴 등의 치료에 중요한 선택입니다. 등의 치료에 여전히 중요한 선택이 되고 있습니다. 이러한 추세는 페니실린 기반 치료의 효능을 향상시키는 새로운 제형과 투여 방법에 대한 지속적인 연구로 보완되고 있습니다. 의료 서비스 제공자들이 내성률 증가에 대응하기 위해 노력하는 가운데, 항생제의 적절한 사용에 대한 강조는 시장 성장을 더욱 촉진하고 제약회사들이 이 중요한 치료 분야에서 혁신을 일으키고 포트폴리오를 확장할 수 있는 기회를 제공합니다.

페니실린 제제 시장 - 주요 인사이트

당사의 리서치 애널리스트의 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 연평균 약 4.20%의 CAGR로 성장할 것으로 예상됩니다.

유형별 세분화에 따르면, 2023년에는 아미노페니실린 계열의 약물이 가장 큰 시장 점유율을 보일 것으로 예측됐습니다.

투여 경로별로는 주사제가 2023년 주요 유형으로 나타났습니다.

용도별로는 호흡기 감염이 2023년 주요 유형으로 꼽혔습니다.

지역별로는 북미가 2023년 수익원 1위를 차지했습니다.

페니실린 제제 시장 - 세분화 분석:

세계 페니실린 제제 시장은 유형, 투여 경로, 용도, 최종사용자 및 지역에 따라 세분화됩니다.

시장은 유형에 따라 천연 페니실린, 아미노 페니실린, 페니실리나아제 내성 페니실린, 스펙트럼 확장 페니실린의 네 가지 범주로 나뉩니다. 아미노페니실린계 페니실린은 광범위한 효능으로 인해 가장 높은 시장 점유율을 차지할 것으로 예상되며, 내성 감염 치료에 중요한 스펙트럼 확장 페니실린이 그 뒤를 이을 것으로 예상됩니다. 천연 페니실린과 페니실리나아제 내성 페니실린이 그 뒤를 잇습니다.

시장은 투여 경로에 따라 경구용과 주사제의 두 가지 범주로 나뉩니다. 주사제는 빠른 효과와 중증 감염에 대한 효과로 인해 우선순위가 높으며, 경구제는 편의성과 외래에서 쉽게 사용할 수 있다는 점에서 우선순위가 근소한 차이로 그 뒤를 잇고 있습니다.

페니실린 제제 시장 - 지리적 인사이트

페니실린 제제 시장은 지역별로 뚜렷한 차이를 보이고 있으며, 북미는 높은 의료 인프라와 높은 항생제 소비율로 선두를 달리고 있습니다. 미국은 연간 6,000만 건 이상의 페니실린계 항생제 처방을 기록하며 큰 비중을 차지하고 있습니다. 독일과 영국과 같은 국가들은 책임감 있는 항생제 사용을 장려하기 위해 엄격한 규제를 시행하고 있지만, 여전히 높은 사용량을 보고하고 있습니다. 아시아태평양에서는 의료비 증가와 감염에 대한 인식 증가가 성장의 원동력이 되고 있으며, 특히 중국은 도시화와 산업화로 인해 항생제 소비가 급증하고 있습니다. 또한, 인도에서는 필수 의약품에 대한 접근성 개선과 같은 노력으로 페니실린 제제 시장이 강화되고 있습니다. 라틴아메리카도 잠재력을 가지고 있으며, 브라질은 의약품 생산능력 확대에 주력하고 있습니다. 각 지역의 고유한 의료 역학 및 규제 프레임워크가 페니실린 수요에 영향을 미치고 있기 때문에 기업은 각 지역의 시장 환경을 활용하기 위해 전략을 조정하는 것이 중요합니다.

페니실린 제제 시장 - 경쟁 상황:

페니실린 제제 시장의 경쟁 환경은 각 지역의 주요 기업들이 각자의 강점을 활용하는 것이 특징입니다. 북미에서는 화이자(Pfizer)와 머크(Merck)가 주요 기여자이며, 화이자(Pfizer)는 연간 2,000만 개 이상의 페니실린을 생산하고 있으며, 높은 수준의 R&D 역량을 보유하고 있습니다. 유럽에서는 GlaxoSmithKline과 Roche와 같은 기업이 기술 혁신과 엄격한 규제 준수에 주력하고 있으며, GSK는 최근 EU 전역에서 책임감 있는 항생제 사용을 장려하는 캠페인을 시작했습니다. 아시아태평양에서는 Hunan Jinzi Pharmaceutical과 Zhejiang Huahai Pharmaceutical이 중요한 기업으로 부상하고 있으며, 특히 중국에서는 항생제 수요 증가에 대응하기 위해 매년 10%의 시장 성장이 예상됩니다. 라틴아메리카에서는 브라질의 Farmanguinhos와 같은 현지 제조업체가 성장하고 있으며 현지 의료 수요를 충족시키기 위해 생산을 확대하고 있습니다. 이들 제조업체는 시장 지위를 강화하고 항생제 내성이라는 세계 과제에 대응하고 다양한 지역 수요에 대응하기 위해 연구와 제휴에 지속적으로 투자하고 있습니다.

목차

제1장 페니실린 제제 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 페니실린 제제의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 페니실린 제제 산업 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 프레임워크 분석

제5장 페니실린 제제 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 페니실린 제제 시장 상황

  • 페니실린 제제 시장 점유율 분석, 2023년
  • 내역 데이터 : 주요 제조업체별
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 페니실린 제제 시장 - 유형별

  • 개요
    • 부문 점유율 분석 : 유형별
    • 천연 페니실린
    • 아미노페니실린
    • 페니실리나아제 내성 페니실린
    • 광범위 페니실린

제8장 페니실린 제제 시장 - 투여 경로별

  • 개요
    • 부문 점유율 분석 : 투여 경로별
    • 경구
    • 주사 가능

제9장 페니실린 제제 시장 - 용도별

  • 개요
    • 부문 점유율 분석 : 용도별
    • 호흡기 감염증
    • 요로감염(UTI)
    • 피부·연조직 감염증
    • 성감염증

제10장 페니실린 제제 시장 - 최종사용자별

  • 개요
    • 부문 점유율 분석 : 최종사용자별
    • 병원
    • 클리닉
    • 재택의료
    • 소매 약국

제11장 페니실린 제제 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 - 페니실린 제제 업계

  • 경쟁 대시보드
  • 기업 개요
    • Alembic Pharmaceuticals Ltd.
    • Aurobindo Pharma Limited
    • Fresenius Kabi AG
    • GlaxoSmithKline plc
    • Hikma Pharmaceuticals PLC
    • Lupin Limited
    • Merck &Co., Inc.
    • Mylan N.V.(Viatris)
    • Novartis International AG
    • Pfizer Inc.
    • Sandoz International GmbH
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Wockhardt Limited
    • Zydus Lifesciences Ltd.
    • 기타

제13장 애널리스트의 전방위 전망

ksm 24.11.15

REPORT HIGHLIGHT

Penicillin Drug Market size was valued at USD 9,102.32 Million in 2023, expanding at a CAGR of 4.20% from 2024 to 2032.

The Penicillin Drug Market encompasses a range of antibiotics derived from Penicillium fungi, primarily used to treat bacterial infections. The increasing prevalence of bacterial infections and the rise in antibiotic prescriptions are major factors contributing to market growth. Additionally, initiatives from organizations like the World Health Organization to combat antibiotic resistance are pushing for greater availability and innovation in penicillin-based treatments. However, challenges such as the growing incidence of antibiotic resistance and stringent regulatory frameworks can restrain market expansion. Opportunities lie in the development of new formulations and combination therapies, as well as rising demand in emerging markets. For instance, the use of penicillin in treating syphilis and rheumatic fever continues to be endorsed by health authorities, highlighting its enduring relevance in modern medicine.

Penicillin Drug Market- Market Dynamics

Rise in Antibiotic Prescriptions Fuels Growth in the Penicillin Drug Market

The rise in antibiotic prescriptions is significantly boosting the Penicillin Drug Market, driven by increasing bacterial infections and a growing aging population. According to the World Health Organization, antibiotic resistance is a major global health issue, leading to higher demand for effective treatments. In 2021, the Centers for Disease Control and Prevention reported that antibiotic prescriptions exceeded 200 million annually in the U.S. alone, with penicillin derivatives remaining a crucial choice for treating conditions such as strep throat and pneumonia. This trend is complemented by ongoing research into novel formulations and delivery methods, enhancing the efficacy of penicillin-based therapies. As healthcare providers strive to combat rising resistance rates, the emphasis on appropriate antibiotic use will further propel the market's growth, presenting opportunities for pharmaceutical companies to innovate and expand their portfolios in this essential therapeutic area.

Penicillin Drug Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.20% over the forecast period (2024-2032)

Based on Type segmentation, Aminopenicillins was predicted to show maximum market share in the year 2023

Based on Route of Administration segmentation, Injectable was the leading type in 2023

Based on Application segmentation, Respiratory Tract Infections was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Penicillin Drug Market- Segmentation Analysis:

The Global Penicillin Drug Market is segmented on the basis of Type, Route of Administration, Application, End-User, and Region.

The market is divided into four categories based on Type: Natural Penicillin, Aminopenicillins, Penicillinase-Resistant Penicillin, and Extended-Spectrum Penicillin. Aminopenicillins are expected to hold the highest market share due to their broad-spectrum efficacy, followed by Extended-Spectrum Penicillin, which is crucial for treating resistant infections. Natural Penicillin and Penicillinase-Resistant Penicillin follow in priority.

The market is divided into two categories based on Route of Administration: Oral and Injectable. Injectable forms are prioritized due to their rapid action and effectiveness in severe infections, while Oral formulations are also significant for their convenience and ease of use in outpatient settings, following closely in preference.

Penicillin Drug Market- Geographical Insights

The Penicillin Drug Market exhibits notable regional variations, with North America leading due to its advanced healthcare infrastructure and high antibiotic consumption rates. The U.S. accounts for a significant share, with over 60 million prescriptions for penicillin-based antibiotics annually. Europe follows closely, where countries like Germany and the UK have implemented stringent regulations promoting responsible antibiotic use, yet still report high usage levels. In Asia-Pacific, rising healthcare expenditures and increased awareness of infectious diseases are driving growth, with China being a key player, where antibiotic consumption has surged in response to urbanization and industrialization. Additionally, initiatives in India, such as improving access to essential medicines, have bolstered the market for penicillin drugs. Latin America shows potential as well, with Brazil focusing on expanding its pharmaceutical manufacturing capabilities. Each region's unique healthcare dynamics and regulatory frameworks influence the demand for penicillin, making it crucial for companies to tailor their strategies to capitalize on local market conditions.

Penicillin Drug Market- Competitive Landscape:

The competitive landscape of the Penicillin Drug Market is characterized by major players across various regions, each leveraging unique strengths. In North America, Pfizer and Merck are key contributors, with Pfizer producing over 20 million units of penicillin annually, benefiting from advanced research and development capabilities. Europe is home to companies like GlaxoSmithKline and Roche, which focus on innovation and compliance with stringent regulations; GSK recently launched a campaign to promote responsible antibiotic usage across the EU. In the Asia-Pacific region, Hunan Jinzi Pharmaceutical and Zhejiang Huahai Pharmaceutical have emerged as significant players, responding to the rising demand for antibiotics, particularly in China, where the market is projected to grow by 10% annually. Latin America is witnessing growth from local manufacturers such as Farmanguinhos in Brazil, which is expanding its production to meet local healthcare needs. These players are continuously investing in research and partnerships to enhance their market positions and address the global challenge of antibiotic resistance while meeting diverse regional demand.

Recent Developments:

In June 2024, Orchid Pharma launched a new antibiotic, Cefepime-Enmetazobactam, in collaboration with Cipla, targeting complicated urinary tract infections and pneumonia. This partnership aims to combat antimicrobial resistance and ensure rapid distribution across India, enhancing healthcare outcomes significantly.

In June 2024, Wockhardt plans to launch its novel antibiotic Zaynich in India by the end of FY25. This drug targets drug-resistant infections and has shown a 100% success rate in compassionate use cases. It is expected to address significant antimicrobial resistance issues globally.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PENICILLIN DRUG MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Alembic Pharmaceuticals Ltd.
  • Aurobindo Pharma Limited
  • Fresenius Kabi AG
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals PLC
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan N.V. (Viatris)
  • Novartis International AG
  • Pfizer Inc.
  • Sandoz International GmbH
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Wockhardt Limited
  • Zydus Lifesciences Ltd.
  • Others

GLOBAL PENICILLIN DRUG MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Natural Penicillins
  • Aminopenicillins
  • Penicillinase-Resistant Penicillins
  • Extended-Spectrum Penicillins

GLOBAL PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Injectable

GLOBAL PENICILLIN DRUG MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Respiratory Tract Infections
  • Urinary Tract Infections (UTIs)
  • Skin and Soft Tissue Infections
  • Sexually Transmitted Infections

GLOBAL PENICILLIN DRUG MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Homecare Settings
  • Retail Pharmacies

GLOBAL PENICILLIN DRUG MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Penicillin Drug Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Penicillin Drug Market Snippet by Type
    • 2.1.2. Penicillin Drug Market Snippet by Route of Administration
    • 2.1.3. Penicillin Drug Market Snippet by Application
    • 2.1.4. Penicillin Drug Market Snippet by End-User
    • 2.1.5. Penicillin Drug Market Snippet by Country
    • 2.1.6. Penicillin Drug Market Snippet by Region
  • 2.2. Competitive Insights

3. Penicillin Drug Key Market Trends

  • 3.1. Penicillin Drug Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Penicillin Drug Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Penicillin Drug Market Opportunities
  • 3.4. Penicillin Drug Market Future Trends

4. Penicillin Drug Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Penicillin Drug Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Penicillin Drug Market Landscape

  • 6.1. Penicillin Drug Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Penicillin Drug Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Natural Penicillins
    • 7.1.3. Aminopenicillins
    • 7.1.4. Penicillinase-Resistant Penicillins
    • 7.1.5. Extended-Spectrum Penicillins

8. Penicillin Drug Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 8.1.2. Oral
    • 8.1.3. Injectable

9. Penicillin Drug Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Respiratory Tract Infections
    • 9.1.3. Urinary Tract Infections (UTIs)
    • 9.1.4. Skin and Soft Tissue Infections
    • 9.1.5. Sexually Transmitted Infections

10. Penicillin Drug Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Homecare Settings
    • 10.1.5. Retail Pharmacies

11. Penicillin Drug Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Penicillin Drug Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Penicillin Drug Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Penicillin Drug Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Penicillin Drug Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Penicillin Drug Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Penicillin Drug Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Alembic Pharmaceuticals Ltd.
    • 12.2.2. Aurobindo Pharma Limited
    • 12.2.3. Fresenius Kabi AG
    • 12.2.4. GlaxoSmithKline plc
    • 12.2.5. Hikma Pharmaceuticals PLC
    • 12.2.6. Lupin Limited
    • 12.2.7. Merck & Co., Inc.
    • 12.2.8. Mylan N.V. (Viatris)
    • 12.2.9. Novartis International AG
    • 12.2.10. Pfizer Inc.
    • 12.2.11. Sandoz International GmbH
    • 12.2.12. Sanofi S.A.
    • 12.2.13. Sun Pharmaceutical Industries Ltd.
    • 12.2.14. Teva Pharmaceutical Industries Ltd.
    • 12.2.15. Wockhardt Limited
    • 12.2.16. Zydus Lifesciences Ltd.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제